Literature DB >> 33982756

Validation of the prognostic value of 9-gene ATE score for IDH wild-type glioblastoma.

Zihao Wang1,2, Lu Gao1,2, Yaning Wang1,2, Mengqi Chang1,2, Hao Xing1,2, Yu Wang1,2, Bing Xing1,2, Wenbin Ma1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33982756      PMCID： PMC8248834          DOI： 10.1093/neuonc/noab058

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  6 in total

1.  Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis.

Authors:  Yong-Wan Kim; Dimpy Koul; Se Hoon Kim; Agda Karina Lucio-Eterovic; Pablo R Freire; Jun Yao; Jing Wang; Jonas S Almeida; Ken Aldape; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2013-03-15       Impact factor: 12.300

2.  Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.

Authors:  Radia M Johnson; Heidi S Phillips; Carlos Bais; Cameron W Brennan; Timothy F Cloughesy; Anneleen Daemen; Ulrich Herrlinger; Robert B Jenkins; Albert Lai; Christoph Mancao; Michael Weller; Wolfgang Wick; Richard Bourgon; Josep Garcia
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

3.  Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.

Authors:  Peng Jiang; Shengqing Gu; Deng Pan; Jingxin Fu; Avinash Sahu; Xihao Hu; Ziyi Li; Nicole Traugh; Xia Bu; Bo Li; Jun Liu; Gordon J Freeman; Myles A Brown; Kai W Wucherpfennig; X Shirley Liu
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

4.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

6.  Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology.

Authors:  Chen Yang; Xiaowen Huang; Yan Li; Junfei Chen; Yuanyuan Lv; Shixue Dai
Journal:  Brief Bioinform       Date:  2021-05-20       Impact factor: 13.994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.